LY-3537031
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 18, 2025
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
(clinicaltrials.gov)
- P1 | N=230 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Jul 2025 ➔ Jul 2026 | Trial primary completion date: Jul 2025 ➔ Jul 2026
Trial completion date • Trial primary completion date • Genetic Disorders • Obesity
September 20, 2024
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
(clinicaltrials.gov)
- P1 | N=230 | Recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Genetic Disorders • Obesity
1 to 2
Of
2
Go to page
1